I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, T&K announced that its wholly-owned subsidiary Anhui T&K Pharmaceutical Co., Ltd. recently received the "Acceptance Notice" for the application for the registration and marketing authorization of Glucosamine Sulfate Capsules issued by the National Medical Products Administration. The National Medical Products Administration reviewed the application for the registration and marketing authorization of the above-mentioned drug and decided to accept it. Glucosamine Sulfate Capsules are suitable for primary and secondary osteoarthritis
According to the Zhitong Finance APP, T&K (301263.SZ) announced that its wholly-owned subsidiary Anhui T&K Pharmaceutical Co., Ltd. recently received the "Acceptance Notice" for the domestic production drug registration application for Glucosamine Sulfate Capsules issued by the National Medical Products Administration. The National Medical Products Administration reviewed the drug registration application for the above-mentioned product and decided to accept it. Glucosamine Sulfate Capsules are suitable for primary and secondary osteoarthritis